4Filed Sep 1, 8:00 PM ET

Jazz (JAZZ) Director Norbert Riedel Sells 1,706 Shares for Taxes

$JAZZ · Jazz Pharmaceuticals plc

Research Summary

AI-generated summary of this SEC filing

Updated

Jazz (JAZZ) Director Norbert Riedel Sells 1,706 Shares for Taxes

What Happened

  • Norbert G. Riedel, a director of Jazz Pharmaceuticals plc, had 1,706 shares disposed on 2026-08-31 to satisfy tax withholding obligations tied to the vesting of previously granted restricted stock units (RSUs). The transactions were recorded as disposals (tax withholding) rather than open-market, discretionary sales.
  • Details: 1,692 shares withheld/sold at $241.39 each for $408,432, and 14 shares withheld/sold at $244.64 each for $3,425 — total ~1,706 shares and ~$411,857.

Key Details

  • Transaction dates/prices: 2026-08-31 — 1,692 @ $241.39; 14 @ $244.64.
  • Total proceeds (approx.): $411,857.
  • Transaction code: F — tax withholding to satisfy tax liability on RSU vesting (footnote: shares sold to satisfy tax obligations arising out of vesting of previously granted RSUs).
  • Filing: Form 4 filed 2026-09-02 for the 2026-08-31 transactions (filed within the normal reporting window; no late-filing flag present).
  • Shares owned after transaction: not disclosed in the provided filing.

Context

  • These were withholding/sale transactions tied to RSU vesting (a common administrative action) rather than a purposeful open-market sale for investment reasons. Such tax-withholding disposals are routine and do not necessarily signal the insider’s view on the company’s stock.
  • Transaction code F is different from P (purchase) or S (open-market sale); it represents withholding/sale to cover taxes.